Navigation Links
Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
Date:6/15/2012

NEW YORK, June 15, 2012 /PRNewswire/ -- ExL Pharma will host the 2nd Pharmaceutical Research Collaborations Summit August 14-15 at the Hyatt Harborside in Boston.

One of the critical questions facing the pharmaceutical industry today is where will future R&D dollars come from. The patent cliff and other forces are making it difficult for large pharmaceutical companies to maintain large-scale internal research departments.  As a result, pharmaceutical companies frequently look outside of their company to benefit from discoveries that may be further along the development pipeline, reducing the financial risk of bringing them further.

The two-day program focuses on various strategies pharmaceutical companies take to benefit from outside research. Sessions will highlight case studies on partnerships between large pharmaceutical and biotech companies, universities, small biotechs, and virtual pharma companies.  Panelists will discuss the different goals of the different institutions, venture capital opportunities, and intellectual property considerations.  Attendees will hear presentations on open innovation case studies, regulatory issues, and the finer points of alliance management.

The diverse speaker staff draws from some of the leading life science research institutions and companies, including MIT, Abbott Ventures, Boston University, Biogen Idec, Tufts, Merck, Millennium, Novartis, Yale, Pfizer, Sanofi, and more. These different points of view will shed light on the dynamics that promise to drive scientific research in coming years.

To find out more information regarding attending the 2nd Pharmaceutical Research Collaborations Summit, please contact Shari Gelfand on sgelfand@exlpharma.com or visit 2nd Pharmaceutical Research Collaborations Summit.

About ExL Pharma

ExL Pharma, a division of ExL Events, Inc., is the industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe, Latin America and various markets. Behind our diverse pharmaceutical event portfolio, ExL's experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of specific audiences and working groups.

Press Contact:
Shari Gelfand
(917) 258-5145
sgelfand@exlpharma.com


'/>"/>
SOURCE ExL Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
2. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
3. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
4. Genesis Biopharma Mentioned Favorably in BioMedReports Article
5. Genesis Biopharma Issues Letter To Shareholders
6. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
7. Questcor Pharmaceuticals Expands Repurchase Program
8. PharmAthene Reports First Quarter 2012 Financial Results
9. Eutropics Pharmaceuticals Receives U.S. Patent for Novel Diagnostic Method
10. PDL BioPharma to Present at Upcoming Conferences
11. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Lajollacooks4u has become a rising hotspot ... rated one of its top attractions. Fortune 500 companies, such as Illumina, Hewlett-Packard, ... unique and intimate team-building experience. , Each event kicks off with an olive oil ...
(Date:5/25/2016)... ... 2016 , ... Scientists at the University of Athens say they have evidence ... hampering the research that could lead to one good one. Surviving Mesothelioma has just ... , The team evaluated 98 mesothelioma patients who got a second ...
(Date:5/24/2016)... 2016   MedyMatch Technology Ltd ., the data analytics ... decision support tools in the emergency room, announced today that ... Advanced Technology Industries (IATI) BioMed Conference. The ... 15th National Life Sciences and Technology Week, and is being ... in Tel Aviv, Israel . Gene ...
(Date:5/23/2016)... , May 23, 2016 Zimmer Biomet Holdings, ... healthcare, today announced that its Board of Directors has approved ... the second quarter of 2016. The cash ... about July 29, 2016 to stockholders of record as of ... of dividends are subject to approval of the Board of ...
Breaking Biology Technology:
(Date:3/11/2016)... , March 11, 2016 ... new market research report "Image Recognition Market by Technology ... (Marketing and Advertising), by Deployment Type (On-Premises and Cloud), ... To 2022", published by MarketsandMarkets, the global market is ... to USD 29.98 Billion by 2020, at a CAGR ...
(Date:3/10/2016)... 2016   Unisys Corporation (NYSE: UIS ) ... (CBP) is testing its biometric identity solution at the Otay ... to help identify certain non-U.S. citizens leaving the country. ... to help determine the efficiency and accuracy of using biometric ... will run until May 2016. --> the ...
(Date:3/9/2016)... , March 9, 2016 ... identified that more than 23,000 public service employees either ... been receiving their salary unlawfully.    --> ... government identified that more than 23,000 public service employees ... had been receiving their salary unlawfully.    --> ...
Breaking Biology News(10 mins):